Rocuronium
Myopathy; Drugs
4th Military Clinical Hospital with Polyclinic, PolandN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Myopathy; Drugs cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE Assiut University | Phase 4 | BB |
Sildenafil Assiut University | Phase 4 | B |
PROPOFOL 4th Military Clinical Hospital with Polyclinic, Poland | N/A | D |
Same molecule, other indications
Rocuronium is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →